Isolation, characterization, and potential application of Acinetobacter baumannii phages against extensively drug-resistant strains
- 10 September 2024
- journal article
- research article
- Published by Springer Nature in Virus Genes
- Vol. 60 (6) , 725-736
Abstract
One of the significant issues in treating bacterial infections is the increasing prevalence of extensively drug-resistant (XDR) strains of Acinetobacter baumannii. In the face of limited or no viable treatment options for extensively drug-resistant (XDR) bacteria, there is a renewed interest in utilizing bacteriophages as a treatment option. Three Acinetobacter phages (vB_AbaS_Ftm, vB_AbaS_Eva, and vB_AbaS_Gln) were identified from hospital sewage and analyzed for their morphology, host ranges, and their genome sequences were determined and annotated. These phages and vB_AbaS_SA1 were combined to form a phage cocktail. The antibacterial effects of this cocktail and its combinations with selected antimicrobial agents were evaluated against the XDR A. baumannii strains. The phages exhibited siphovirus morphology. Out of a total of 30 XDR A. baumannii isolates, 33% were sensitive to vB_AbaS_Ftm, 30% to vB_AbaS_Gln, and 16.66% to vB_AbaS_Eva. When these phages were combined with antibiotics, they demonstrated a synergistic effect. The genome sizes of vB_AbaS_Ftm, vB_AbaS_Eva, and vB_AbaS_Gln were 48487, 50174, and 50043 base pairs (bp), respectively, and showed high similarity. Phage cocktail, when combined with antibiotics, showed synergistic effects on extensively drug-resistant (XDR) strains of A. baumannii. However, the need for further study to fully understand the mechanisms of action and potential limitations of using these phages is highlighted.Keywords
Funding Information
- Hossein Hosseini-Nave1 (KMU.AC.IR.400000652)
This publication has 63 references indexed in Scilit:
- Phage treatment of Pseudomonas aeruginosa yields a phage-resistant population with different susceptibility to innate immune responses and mild effects on metabolic profilesMicrobiological Research, 2024
- Genetic engineering of bacteriophages: Key concepts, strategies, and applicationsBiotechnology Advances, 2023
- Bacteriophage Therapy for Critical and High-Priority Antibiotic-Resistant Bacteria and Phage Cocktail-Antibiotic Formulation PerspectiveFood and Environmental Virology, 2021
- Engineered Bacteriophage Therapeutics: Rationale, Challenges and FutureBioDrugs, 2021
- Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and extensively drug-resistant Acinetobacter baumannii infections: A systematic review and network meta-analysisJournal of Global Antimicrobial Resistance, 2021
- A novel vieuvirus from multidrug-resistant Acinetobacter baumanniiArchives of Virology, 2021
- Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?Clinical Therapeutics, 2020
- Prevalence and characterization of virulence genes in Escherichia coli isolated from piglets suffering post‐weaning diarrhoea in Shandong Province, ChinaVeterinary Medicine and Science, 2019
- Bacteriophage-host arm race: an update on the mechanism of phage resistance in bacteria and revenge of the phage with the perspective for phage therapyApplied Microbiology and Biotechnology, 2019
- Isolation of Phage via Induction of Lysogens2009